RUNX1 and metabolic dysfunction-associated steatotic liver disease: Regarding our previous study, we reported that the mRNA and protein expression of RUNX1 in liver seems to be involved in first steps of NAFLD with a proangiogenic-repairing role; meanwhile, RUNX1 appears to be downregulated in the NASH stage [21].